GHUCCTS

News

Share This
  • Feb 21, 2020

Monumental clinical trial leverages GHUCCTS Trial Innovation Network

The Memory Improvement through Nicotine Dosing (MIND) study team leveraged the GHUCCTS Trial Innovation Network (TIN) to identify collaborators for the trial through an EHR-based cohort assessment. The clinical trial was placed at the Georgetown University Memory Disorders Program. Investigators also utilized the TIN to conduct community engagement studios that allow for meaningful involvement of diverse groups of stakeholders in the planning and implementation of research.

The MIND study is "the largest and longest of its kind, enrolling up to 300 people in 23 states to see if a nicotine patch, developed to help smokers kick the habit, can also help sharpen memory and attention". NBC4 Washington recently featured the study.

To learn more about how you can leverage the TIN for your multicenter trial or to even become a site investigator on a trial utilizing the TIN, please visit our GHUCCTS TIN page.

Related News
CLIC Showcases GHUCCTS TL1's Mentorship Program

CLIC Showcases GHUCCTS TL1's Mentorship Program

Jan 06, 2022

GHUCCTS' TL1 mentorship program is one of nine CTSA's to be featured this month in the Center for Leading Innovation and Collaboration's (CLIC) Insights to Inspire.

2021 REKS Summer Series Recording: Pathway to Decentralized Clinical Trials

Nov 18, 2021

Session recordings and slide presentations are now available from the 2021 REKS Summer Series Recording: Pathway to Decentralized Clinical Trials.

GHUCCTS Announces 2021-2022 Translational Biomedical Science (TBS) Program Scholars

Oct 07, 2021

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is proud to introduce our 2021-2022 Translational Biomedical Science (TBS) program scholars.

Close